Polyacrylamide Hydrogel Differences: Getting Rid of the Confusion
December 2011 | Volume 10 | Issue 12 | Original Article | 1370 | Copyright © 2011
Polymer hydrogels have been used for many years in European and Asian countries, and these products are often considered to be the same material in different packaging. This, however, is not the case. Performance and safety profiles depend on many factors including chemical and physical characteristics (including rheological properties), manufacturing process and control (cross linking, impurities, stability, etc.), injection technique, and interaction with surrounding tissues. Polyacrylamide hydrogel (PAAH) products, although often considered equal, have clear differences in composition, manufacturing, and injection technique as well as ability to interact with surrounding tissues, characteristics that determine the safety and effectiveness profiles of each of these gels.
J Drugs Dermatol. 2011;10(12):1370-1375.
Purchase Original Article
Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.
Download the original manuscript as it was published in the JDD.
Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.
To get access to JDD's full-text articles and archives, upgrade here.
Save an unformatted copy of this article for on-screen viewing.
Print the full-text of article as it appears on the JDD site.→ proceed | ↑ close
Polyacrylamide hydrogels (PAAH) have been used for many years in European and Asian countries, and they have been and some still are produced by a number of different manufacturers (Table 1). None of the products are currently marketed in the U.S., but a pivotal clinical study of Aquamid (Contura International A/S, Denmark) has recently been completed in the U.S.
The PAAH products are often considered to be the same material in different packaging, but this is not the case. There are important differences in the composition of the hydrogels, their manufacturing and control, injection technique used to implant the gels, and their ability to interact with the tissue into which they are injected. All these factors are likely to impact the performance and/or safety profile of the PAAH product.
Different polymer hydrogels have different chemical and physical structures: Bio-Alcamid (Polymekon, Italy), for example, is reported to be composed of polymers of alkylimide units;1 Evolution (ProCytech, France) is composed of positively charged polyvinyl microspheres suspended in an acrylamide polymer;2 Aquamid is composed solely of a cross-linked polyacrylamide.3 Moreover, there are different cross-linking techniques applied for the various hydrogels, which have a significant impact on the physical and chemical product characteristics and thereby on the tissue interaction and longevity. Information on details regarding stability, visco-elastic properties, pH, and dry matter content of different PAAH products is sparse and stems mainly from the manufacturers. Among the PAAH products, Interfall, appeared at the market in the early 90s and was invented and patented in Ukraine. The first world conference on its application was held in Kiev in November 2000. Subsequently a number of similar preparations emerged: Formacryl, Bioformacryl, Cosmogel, Argiform (from Russia), and Amazingel (from China).
In the following, three of the best known and most widely used hydrogels will be more thoroughly described with respect to these characteristics, and their differences will be highlighted in Tables 1 and 2. Unless otherwise indicated, all analyzes have been carried-out by Chempilots A/S, Farum, Denmark.
Characteristics of Different HydrogelsBio-Alcamid
The gel started out as Formacryl, a product manufactured by the Russian company, Bioform, but in 2000, the product was manufactured by the Italian company, B&B Dental SRL (Progen, now Polymekon) and the name changed to BioFormacryl-the forerunner of Bio-Alcamid.